ES340262A1 - Procedimiento para preparar una composicion de sulfonamida. - Google Patents

Procedimiento para preparar una composicion de sulfonamida.

Info

Publication number
ES340262A1
ES340262A1 ES340262A ES340262A ES340262A1 ES 340262 A1 ES340262 A1 ES 340262A1 ES 340262 A ES340262 A ES 340262A ES 340262 A ES340262 A ES 340262A ES 340262 A1 ES340262 A1 ES 340262A1
Authority
ES
Spain
Prior art keywords
sulphonamide
methyl
pyrimidine
diamino
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES340262A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES340262A1 publication Critical patent/ES340262A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electric Connection Of Electric Components To Printed Circuits (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES340262A 1966-05-09 1967-05-08 Procedimiento para preparar una composicion de sulfonamida. Expired ES340262A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH671666 1966-05-09

Publications (1)

Publication Number Publication Date
ES340262A1 true ES340262A1 (es) 1968-06-01

Family

ID=74187416

Family Applications (1)

Application Number Title Priority Date Filing Date
ES340262A Expired ES340262A1 (es) 1966-05-09 1967-05-08 Procedimiento para preparar una composicion de sulfonamida.

Country Status (16)

Country Link
US (1) US3551564A (cg-RX-API-DMAC7.html)
JP (1) JPS5017524B1 (cg-RX-API-DMAC7.html)
BE (1) BE698102A (cg-RX-API-DMAC7.html)
CH (1) CH544053A (cg-RX-API-DMAC7.html)
DE (1) DE1617521C3 (cg-RX-API-DMAC7.html)
DK (1) DK117520B (cg-RX-API-DMAC7.html)
ES (1) ES340262A1 (cg-RX-API-DMAC7.html)
FI (1) FI48975C (cg-RX-API-DMAC7.html)
FR (1) FR1523606A (cg-RX-API-DMAC7.html)
GB (1) GB1176395A (cg-RX-API-DMAC7.html)
GR (1) GR35814B (cg-RX-API-DMAC7.html)
IL (1) IL27876A (cg-RX-API-DMAC7.html)
IT (1) IT1143624B (cg-RX-API-DMAC7.html)
NL (1) NL140736B (cg-RX-API-DMAC7.html)
NO (1) NO127486B (cg-RX-API-DMAC7.html)
SE (1) SE348112B (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZM3271A1 (en) * 1970-03-13 1972-10-23 Wellcome Found Improvements in or relating to injectable therapeutic compositions
US3728452A (en) * 1971-01-20 1973-04-17 Abic Ltd Water-soluble composition comprising sulfadimidine and pyrimethamine
IT1044231B (it) * 1972-03-16 1980-03-20 Hoffmann La Roche Combinazione di sostanze attive utile per combattere infezioni da batteri gram positivi e gran negativi
DE2342213C3 (de) * 1972-10-12 1979-10-18 F. Hoffmann-La Roche & Co Ag, Basel (Schweiz) Verwendung von potenzierten SuIf onamiden bei der Behandlung oder Verhinderung von Fischinfektionen
US3985876A (en) * 1973-01-05 1976-10-12 Burroughs Wellcome Co. Chemotherapeutic solutions containing a sulphur and a salt of a 2,4-diamino-5-benzylpyrimidine
GB1485383A (en) * 1973-09-24 1977-09-08 Wellcome Found Injectable non-aqueous therapeutic compositions
GB1485382A (en) * 1973-09-24 1977-09-08 Wellcome Found Injectable therapeutic compositions
US4039543A (en) * 1974-12-24 1977-08-02 Hoffmann-La Roche Inc. Benzylpyrimidines
DK136934B (da) * 1976-02-06 1977-12-19 Rosco As Fremgangsmåde til fremstilling af en klar, stabil, injicerbar opløsning indeholdende et sulfonamid og en potentiator.
DE2631780C3 (de) * 1976-07-15 1981-11-19 Basf Ag, 6700 Ludwigshafen Sulfonamid-Trimethoprim-Lösungen
DE2731013C2 (de) * 1977-07-08 1982-07-15 Lentia Gmbh Verfahren zur Herstellung einer wäßrigen Infusionslösung
JPS54154775A (en) * 1978-05-24 1979-12-06 Wellcome Found Benzylpyrimidine derivative
DE2963408D1 (en) 1978-08-01 1982-09-16 Ciba Geigy Ag Stable medicinal solution on the basis of 2,6-diamino-5-(3',4',5'-trimethoxybenzyl)-pyrimidine(trimethoprim) and a sulphonamide, process for preparing and using it
US4303643A (en) * 1979-07-05 1981-12-01 Pfizer Inc. Sulfonamide compositions
HU180740B (en) * 1979-11-27 1983-04-29 Egyt Gyogyszervegyeszeti Gyar Process for producing sulfonamide-containing,injectable pharmaceutical composition of prolongated activity
AR220263A1 (es) * 1980-02-19 1980-10-15 Bago Lab Sa Procedimiento para obtener una preparacion inyectable de sulfonamida potenciada de baja irritabilidad
CH647412A5 (de) * 1980-03-25 1985-01-31 Hoffmann La Roche Pharmazeutische praeparate.
US4374826A (en) * 1980-07-21 1983-02-22 Pfizer Inc. Sulfonamide compositions
EP4417701A4 (en) * 2021-10-12 2025-03-05 Daan Gene Co., Ltd. IN VITRO PRESERVATIVES FOR DIAGNOSTIC REAGENTS AND USE THEREOF

Also Published As

Publication number Publication date
SE348112B (cg-RX-API-DMAC7.html) 1972-08-28
FI48975C (fi) 1975-03-10
DE1617521C3 (de) 1979-09-06
DE1617521B2 (de) 1979-01-04
CH544053A (de) 1973-11-15
IT1143624B (it) 1986-10-22
GB1176395A (en) 1970-01-01
DE1617521A1 (de) 1972-02-10
JPS5017524B1 (cg-RX-API-DMAC7.html) 1975-06-21
BE698102A (cg-RX-API-DMAC7.html) 1967-11-08
IL27876A (en) 1971-10-20
FR1523606A (fr) 1968-05-03
US3551564A (en) 1970-12-29
NL6706474A (cg-RX-API-DMAC7.html) 1967-11-10
DK117520B (da) 1970-05-04
NL140736B (nl) 1974-01-15
GR35814B (el) 1968-11-04
FI48975B (cg-RX-API-DMAC7.html) 1974-12-02
NO127486B (cg-RX-API-DMAC7.html) 1973-07-02

Similar Documents

Publication Publication Date Title
ES340262A1 (es) Procedimiento para preparar una composicion de sulfonamida.
AR018452A1 (es) Compuestos antibioticos de oxazolidinona sustituida, proceso para su preparacion, metodo para producir un efecto antibacteriano, composicionesfarmaceuticas que los contienen y su uso para preparar medicamentos
AR051387A1 (es) Analogos de anilino-pirimidina
AR021354A1 (es) Procedimiento para la preparacion de un compuesto derivado de quinolina y un procedimiento para preparar una composicion farmaceutica
GB1186723A (en) Basically Substituted Bis-Benzimidazole derivatives and process for their manufacture
ES2240943T3 (es) Soluciones colorantes acuosas.
DK1755606T4 (da) Quinazolinonderivater, der er anvendelige som vanilloid-antagonister
US4995885A (en) Concentrated aqueous dye solutions for dyeing paper
CY1105396T1 (el) Επιδιαλυτωμενα σωματιδια pymetrozine
ECSP066343A (es) 6-(1,1-difluoroalquil)-4-aminopicolinatos y uso como herbicidas
ES2127191T3 (es) Derivados de diamino-s-triazinona.
ES347814A1 (es) Procedimiento para el tratamiento de blanqueadores opticos de dificil solubilidad en agua.
AR057203A1 (es) Derivados de acidos vinilogos
GB1094343A (en) Azo dyestuffs
ES417382A1 (es) Procedimiento para la obtencion de compuestos azoicos basi-cos, libres de grupos acido sulfonico.
ZA200409272B (en) Yellow anionic disazo dyes.
GB564713A (en) Improvements in or relating to the formation of coloured photographic images by colour development
GB1060253A (en) New basic monoazo dyestuffs containing a benzimidazole or benztriazole nucleus
CL2024004080A1 (es) Compuestos derivados de pirimidindiona, composición farmacéutica, y uso para tratar cáncer.
ES334972A1 (es) Procedimiento para la preparacion de colorantes azoicos.
TW200702397A (en) Aqueous solutions of direct dyes
GB986644A (en) Novel derivatives of salicylic acid and preparations thereof
GB1121723A (en) Stable aqueous dispersions of o-dianisidine fast to storing, for the preparation ofwater-insoluble azo dyestuffs on fibrous materials
TH1801002074A (th) สารอนุพันธ์อะมิโน-ไตรอะโซล ไกลโคไซด์ชนิดใหม่ (New amino-triazole glycoside derivatives)
GB1112146A (en) New azo dyes